Back to search

University of Thessaly (UTH)

Επίδραση του ινοτρόπου παράγοντα λεβοσιμενδάνης σε ασθενείς με συστολική δυσλειτουργία της αριστερής κοιλίας σε διάφορες αιμοδυναμικές μετρήσεις

Abstract

dc:description

Background: Beta-blockers, are frequently prescribed in heart failure patients, according to current guidelines. Consequently, a continuously increasing percentage of people suffering from decompensated heart failure, take a b-blocker nowadays. Positive inotropic treatment, is indicated in cases not responding to vasodilators and diuretics. In case, a patient is already on a b-blocker, usual doses of dobutamine are ineffective, and higher doses may deteriorate patient status, due to increased peripheral resistance. On the other hand, levosimendan, a newer positive inotropic agent, does not act through adrenergic receptors, as dobutamine does. Aim : To evaluate the influence of chronic b-blockade on haemodynamic parameters of patients with decompensated heart failure, treated with levosimendan Methods and Patients: 18 patients with acutely decompensated heart failure, needing inotropic treatment (8 on chronic b-blockade), were included in this study. Prerequisities for a patient to be included in the study, were to have an ejection fraction below 0.35, his or her cardiac index to be below 2.5 l/min/m2 and wedge pressure above 15 mm Hg. Ejection fraction was calculated echocardiographically, by using Simpson’s method, and cardiac index and wedge pressure by inserting a four lumen thermodilution catheter. Heart rate, arterial pressure, central venous pressure, pulmonary and peripheral resistance, were also calculated in all patients. After all the above baseline measurements had been completed, levosimendan was started intravenously, to all patients, on an initial dose of 24 γ/kg for 10 minutes, followed by an infusion of 0.1γ/kg/min for 24 hours, and all the measurements, except for the ejection fraction, were, afterwards, repeated. Haemodynamic measurements, before and after levosimendan infusion, were compared in each group (non-taking, and taking b-blocker) by using the pair t test. Results : Cardiac index and wedge pressure, significantly improved in all patients, after levosimendan infusion. In the non-taking b-blocker group, cardiac index increased by 43.8% and wedge pressure decreased by 33% (p<0.001). In the b-blocker taking group, the figures were 17.72% and 17.5% respectively (p<0.001). Statistically significant reductions, were, also, recorded in peripheral resistance, in both groups, 31% and 15% respectively (p<0.001). Similar results were recorded for the pulmonary resistance, which decreased in both groups by 44.5% and 25% respectively (p<0.001). Conclusions : Chronic treatment by a b-blocker in heart failure, does not neutralize haemodynamic improvement caused by levosimendan, in the case of acute decompensation. Consequently, levosimendan administration does not have as a prerequisite discontinuation of the b-blocker, as it happens if dobutamine is infused, instead of levosimendan.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kirlidis, Themistoklis
  • Κυρλίδης, Θεμιστοκλής

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17187

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kirlidis, Themistoklis; Κυρλίδης, Θεμιστοκλής. Επίδραση του ινοτρόπου παράγοντα λεβοσιμενδάνης σε ασθενείς με συστολική δυσλειτουργία της αριστερής κοιλίας σε διάφορες αιμοδυναμικές μετρήσεις. University of Thessaly (UTH), 2008. http://hdl.handle.net/10442/hedi/17187